Supplements

BEST PRACTICES IN: Oral Cancer Therapies: Important Prescribing Considerations

Publish date: September 24, 2015
Sponsored by Novartis Pharmaceuticals
PDF Download

 

A supplement to The Journal of Community and Supportive Oncology. This supplement was sponsored by Novartis Pharmaceuticals.

To view the supplement, click the image to the right

Recommended Reading

A qualitative exploration of supports and unmet needs of diverse young women with breast cancer
MDedge Hematology and Oncology
Effects of a self-care education program on quality of life of patients with gastric cancer after gastrectomy
MDedge Hematology and Oncology
Generalizations of a generalist — common themes among systemic therapies for common cancers
MDedge Hematology and Oncology
Topical resiquimod effective for early-stage cutaneous T-cell lymphoma
MDedge Hematology and Oncology
Meta-analysis confirms no OS benefit from antiangiogenics for NSCLC patients
MDedge Hematology and Oncology
Histologic information can’t replace recurrence score
MDedge Hematology and Oncology
Inflammation, coagulation may contribute to CM pathogenesis
MDedge Hematology and Oncology
Imaging provides clearer picture of HSCs
MDedge Hematology and Oncology
Team identifies new virus in blood supply
MDedge Hematology and Oncology
Abs from transplanted AML patients enhance GvL effect in vitro
MDedge Hematology and Oncology